Complex analysis of the personalized pharmacotherapy in the management of COVID-19 patients and suggestions for applications of predictive, preventive, and personalized medicine attitude.

Authors:
Wang LY; Cui JJ; OuYang QY; Zhan Y; Wang YM and 7 more

Journal:
EPMA J

Publication Year: 2021

DOI:
10.1007/s13167-021-00247-0

PMCID:
PMC8283099

PMID:
34306260

Journal Information

Full Title: EPMA J

Abbreviation: EPMA J

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Medicine, Research & Experimental

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approvalNot applicable. Consent to participateNot applicable. Consent for publicationNot applicable. Conflict of interestThe authors declare no conflict of interest. Conflict of interest The authors declare no conflict of interest."

Evidence found in paper:

"Funding This work was supported by the National Natural Science Foundation of China (82073943, 81773823, 81974511), National Science and Technology Major Project of China (2017ZX09304014, 2020ZX09201010), Hunan Provincial Innovation Foundation for Postgraduate (CX20190155), Hunan Cancer Hospital Climb Plan (YF2020011) and Graduate students independently explore innovative projects of central south university, China (2018zzts252, 2020zzts275)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025